America

Giffords' Condition: 'No Change Is Good And We Have No Change,' Dr. Says

"We're not out of the woods yet," Dr. G. Michael Lemole, section chief of neurosurgery at University Medical Center in Tucson, just told reporters in a briefing about the condition of Rep. Gabrielle Giffords (D-AZ) and others wounded in Saturday's shooting rampage.

Dr. G. Michael Lemole, left, and Dr. Peter Rhee during a news conference in Tucson, Ariz., Sunday, Jan. 9, 2011. i i

hide captionDr. G. Michael Lemole, left, and Dr. Peter Rhee during a news conference in Tucson, Ariz., Sunday, Jan. 9, 2011.

Chris Carlson/AP
Dr. G. Michael Lemole, left, and Dr. Peter Rhee during a news conference in Tucson, Ariz., Sunday, Jan. 9, 2011.

Dr. G. Michael Lemole, left, and Dr. Peter Rhee during a news conference in Tucson, Ariz., Sunday, Jan. 9, 2011.

Chris Carlson/AP

Giffords, 40, was shot in the head. "At this phase in the game, no change is good and we have no change," Lemole said. The congresswoman continues to respond — for example, by moving her fingers — to questions posed by her doctors.

CAT scans, Lemole added, show there's been "no progression of ... swelling" in her brain.

Dr. Peter Rhee, the hospital's trauma chief, said that eight patients remain at the hospital. Two, including Giffords, are in intensive care, he said. One of those two is still in "critical" condition — he didn't say specifically that Giffords is that person, but her condition has previously been described as critical. Five patients are in "serious" condition. Two are in "good" condition.

Six people were killed in the rampage. Another 14 were wounded.

Update at 12:17 p.m. ET: The briefing just ended. Dr. Rainer Gruessner, head of surgery, told reporters the hospital will next update them on the patients' conditions on Wednesday.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: